Neonatal metabolic alkalosis and mild diuresis resulting from torasemide self-medication by the mother: a case report [PDF]
Background Torasemide, a loop diuretic, is rarely used for pregnant women because of the risk of reduced placental blood flow resulting from decreased circulating plasma volume.
Yumi Kitahiro +9 more
doaj +3 more sources
Effects of bisoprolol combined with torasemide on cardiac electrophysiology in patients with acute myocardial infarction and heart failure [PDF]
ObjectiveThis paper aims to assess the impact of bisoprolol combined with torasemide on cardiac electrophysiological parameters in acute myocardial infarction (AMI) patients complicated by heart failure (HF).MethodsA total of 140 AMI-HF patients were ...
Li Jing, Qiangwei Shi, Shihao Zhao
doaj +3 more sources
Evaluation of response to combination therapy with enalapril and torasemide in dogs with mitral valve disease [PDF]
The present study was carried out with the objective of evaluating the response to a combination therapy of enalapril and torasemide in dogs with mitral valve disease (MVD).
J. Greeshma +4 more
doaj +3 more sources
Aim. To study the efficacy of loop diuretic torasemide compared with furosemide consisting of combination therapy in patients with chronic heart failure (CHF).Material and methods.
S. F. Berkinbaev +2 more
doaj +6 more sources
Tolerance of torasemide in cats with congestive heart failure: a retrospective study on 21 cases (2016–2019) [PDF]
Background In dogs with congestive heart failure (CHF), the efficacy of torasemide, a loop diuretic, has been demonstrated. However, unlike in dogs and humans little has been described about the use of torasemide in the cat with spontaneous CHF.
Camille Poissonnier +14 more
doaj +2 more sources
Stability of furosemide and torasemide in parenteral nutrition admixture [PDF]
Furosemide and torasemide (loop diuretics) are used to treat hypertension or pulmonary edema. They are often administered in the parenteral route. In critically ill patients, there is a problem of a limited number of venous accesses, which complicates ...
Szymon Tomczak +2 more
doaj +2 more sources
Pharmacokinetic and pharmacodynamic properties of orally administered torasemide in healthy cats
Background In people and dogs, torasemide has higher bioavailability, longer half‐life, and longer duration of action than equivalent doses of furosemide but data regarding pharmacological properties of torasemide in cats are limited. Objective To assess
Marine Roche‐Catholy +8 more
doaj +2 more sources
Population Pharmacokinetics and Pharmacodynamics Modeling of Torasemide and Furosemide After Oral Repeated Administration in Healthy Dogs [PDF]
Torasemide is a loop diuretic licensed in dogs for cardiogenic pulmonary oedema. The aim of this pharmacokinetic-pharmacodynamic (PK/PD) study was to define an optimally effective dosage regimen based on preclinical data.
Ludovic Pelligand +7 more
doaj +2 more sources
<i>UMOD</i> Genotype-Blinded Trial of Ambulatory Blood Pressure Response to Torasemide. [PDF]
BACKGROUND: UMOD (uromodulin) has been linked to hypertension through potential activation of Na+-K+-2Cl− cotransporter (NKCC2), a target of loop diuretics.
McCallum L +14 more
europepmc +2 more sources
Synthesis and Characterization of Related Substances of Torasemide
Torasemide, a pyridine-3-sulfonylurea derivative, is a high-efficiency loop diuretic. During the process development of torasemide, five process-related substances, which have been specified in the pharmacopeia, would be produced.
Jiong Chen +3 more
doaj +2 more sources

